I agree that this site is using cookies. You can find further informations here.
X
Gill, Saar
157  results:
Online X
Search for persons X
?
1

Preconditioning Frailty Phenotype Influences Survival and R..:

Sung, Anthony D. ; Koll, Thuy ; Gier, Shannon H....
Transplantation and Cellular Therapy.  30 (2024)  4 - p. 415.e1-415.e16 , 2024
Link: https://doi.org/10.1016/..
 
?
2

ACT To Sustain: Adoptive Cell Therapy To Sustain Access to ..:

Gardner, Rebecca A. ; White, Claire ; Elsallab, Magdi...
Transplantation and Cellular Therapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Interim Results of a Phase I/II Study of Intermediate-Dose ..:

Hyder, Mustafa A. ; McCurdy, Shannon R. ; Sabina, Ruby...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S284-S285 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Hypomethylating agents are associated with high rates of he..:

Connor, Matthew P. ; Prathapa, Neeharika ; Frey, Noelle V....
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
5

Interim Results of a Phase I/II Trial of Intermediate-Dose ..:

McCurdy, Shannon R. ; Hyder, Mustafa A. ; Sabina, Ruby...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S2-S3 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Post-Transplant Frailty Phenotype Predicts Survival:

Hadjis, Ashley D. ; White, Griffin W. ; Gill, Saar I....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S407-S408 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Deletion of CD38 enhances CD19 chimeric antigen receptor T ..:

Veliz, Kimberly ; Shen, Feng ; Shestova, Olga...
Molecular Therapy: Oncology.  32 (2024)  2 - p. 200819 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Clofarabine and Busulfan Myeloablative Conditioning in Allo..:

Connor, Matthew P. ; Loren, Alison W. ; Hexner, Elizabeth O....
Transplantation and Cellular Therapy.  29 (2023)  2 - p. 113-118 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Good CARMA: Turning bad tumor‐resident myeloid cells good w..:

Snyder, Christopher M. ; Gill, Saar I.
Immunological Reviews.  320 (2023)  1 - p. 236-249 , 2023
Link: https://doi.org/10.1111/..
 
?
10

Real‐world effectiveness of intensive chemotherapy with 7&3..:

Matthews, Andrew H. ; Perl, Alexander E. ; Luger, Selina M....
American Journal of Hematology.  98 (2023)  8 - p. 1254-1264 , 2023
Link: https://doi.org/10.1002/..
 
?
11

One versus two sets of busulfan therapeutic drug monitoring..:

Chippendale, Lindsey ; Freyer, Craig W ; Carulli, Alison...
Journal of Oncology Pharmacy Practice.  30 (2023)  5 - p. 802-810 , 2023
Link: https://doi.org/10.1177/..
 
?
12

Frailty Phenotype Declines in Older Patients after Allogene..:

McCurdy, Shannon R. ; Gier, Shannon H. ; Gill, Saar...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S51 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Hypoimmune cells resist rejection in monkeys:

Borrero Borrego, Asuncion ; Gill, Saar
Nature Biotechnology.  , 2023
Link: https://doi.org/10.1038/..
 
?
14

CD38 as a pan-hematologic target for chimeric antigen recep..:

Glisovic-Aplenc, Tina ; Diorio, Caroline ; Chukinas, John A....
Blood Advances.  7 (2023)  16 - p. 4418-4430 , 2023
Link: https://doi.org/10.1182/..
 
?
15

P449: PROTEOGENOMIC PROFILING OF DIAGNOSTIC AND RELAPSE SAM..:

Glisovic-Aplenc, Tina ; Liddle, Jen ; Cao, Lusha...
HemaSphere.  7 (2023)  S3 - p. e37582f2 , 2023
Link: https://doi.org/10.1097/..
 
1-15